Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonegran in Binge Eating Disorder Associated With Obesity
NCT00221442Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Aug 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in binge eating disorder (BED) comparing Zonegran with Placebo (2 arms). Primary endpoint: frequency of binge eating episodes at 16 weeks. Started Aug 2005; status: completed.
02
Drugs
zonisamide
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT00221442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221442.